Literature DB >> 14642636

Fatal liver failure with atorvastatin.

Ludwig Perger, Malcolm Kohler, Karin Fattinger, Renata Flury, Peter J Meier, Christiane Pauli-Magnus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14642636     DOI： 10.1016/s0168-8278(03)00464-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  8 in total

1.  Jaundice due to suspected statin hepatotoxicity: a case series.

Authors:  Ottar M Bergmann; Gudjon Kristjansson; Jon G Jonasson; Einar S Björnsson
Journal:  Dig Dis Sci       Date:  2011-11-11       Impact factor: 3.199

2.  Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.

Authors:  Anita Conforti; Lara Magro; Ugo Moretti; Stefania Scotto; Domenico Motola; Francesco Salvo; Barbara Ros; Roberto Leone
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Statin associated hepatic adverse effects: a retrospective review from a regional hospital in sultanate of oman.

Authors:  Jimmy Jose; Faisal Abdullah Ali Al-Tamimi; Manal Mahmoud Helal; Beena Jimmy; Qasim Al Riyami
Journal:  Oman Med J       Date:  2014-09

Review 4.  Statin-induced Liver Injury Patterns: A Clinical Review.

Authors:  Leon D Averbukh; Alla Turshudzhyan; David C Wu; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2022-01-10

Review 5.  Lipid-lowering agents that cause drug-induced hepatotoxicity.

Authors:  Sidharth S Bhardwaj; Naga Chalasani
Journal:  Clin Liver Dis       Date:  2007-08       Impact factor: 6.126

6.  Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.

Authors:  Mark W Russo; Jay H Hoofnagle; Jiezhun Gu; Robert J Fontana; Huiman Barnhart; David E Kleiner; Naga Chalasani; Herbert L Bonkovsky
Journal:  Hepatology       Date:  2014-05-13       Impact factor: 17.425

7.  High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort.

Authors:  Alan T Clarke; Paul C D Johnson; Gillian C Hall; Ian Ford; Peter R Mills
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

8.  Risk of Statin-Induced Hypertransaminasemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Rosanna Villani; Eliano Pio Navarese; Francesco Cavallone; Jacek Kubica; Francesco Bellanti; Antonio Facciorusso; Gianluigi Vendemiale; Gaetano Serviddio
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-05-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.